Connor, Clark & Lunn Investment Management Ltd. Tandem Diabetes Care Inc Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 515,062 shares of TNDM stock, worth $17.2 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
515,062
Previous 272,097
89.29%
Holding current value
$17.2 Million
Previous $11.5 Million
60.82%
% of portfolio
0.09%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding TNDM
# of Institutions
346Shares Held
70.9MCall Options Held
3.11MPut Options Held
181K-
Black Rock Inc. New York, NY11.1MShares$371 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.44MShares$248 Million0.0% of portfolio
-
State Street Corp Boston, MA2.77MShares$92.2 Million0.0% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.72MShares$90.8 Million1.47% of portfolio
-
Gw&K Investment Management, LLC Boston, MA2.12MShares$70.8 Million0.65% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $2.14B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...